Sensus Healthcare Analyst Ratings
Sensus Healthcare Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 02/10/2023 | 63.84% | Alliance Global Partners | $16.5 → $14.5 | Maintains | Buy |
| 11/04/2022 | 86.44% | Alliance Global Partners | $17.5 → $16.5 | Maintains | Buy |
| 05/06/2022 | 80.79% | HC Wainwright & Co. | $13 → $16 | Maintains | Buy |
| 03/03/2022 | 46.89% | HC Wainwright & Co. | $12 → $13 | Maintains | Buy |
| 02/14/2022 | 35.59% | HC Wainwright & Co. | $10 → $12 | Maintains | Buy |
| 12/02/2021 | 12.99% | HC Wainwright & Co. | $9 → $10 | Maintains | Buy |
| 11/05/2021 | 1.69% | HC Wainwright & Co. | $7 → $9 | Maintains | Buy |
| 08/06/2021 | -20.9% | HC Wainwright & Co. | $6 → $7 | Maintains | Buy |
| 03/01/2021 | -32.2% | HC Wainwright & Co. | $4 → $6 | Maintains | Buy |
| 02/26/2021 | -32.2% | Roth Capital | $4 → $6 | Maintains | Buy |
| 11/09/2020 | -54.8% | HC Wainwright & Co. | $5 → $4 | Maintains | Buy |
| 05/11/2020 | -66.1% | B. Riley Securities | $5.5 → $3 | Maintains | Neutral |
| 05/08/2020 | -43.5% | HC Wainwright & Co. | $8 → $5 | Reiterates | → Buy |
| 11/07/2019 | -37.85% | B. Riley Securities | $14 → $5.5 | Downgrades | Buy → Neutral |
| 09/19/2018 | 12.99% | Maxim Group | $9 → $10 | Maintains | Buy |
| 08/27/2018 | 58.19% | HC Wainwright & Co. | → $14 | Initiates Coverage On | → Buy |
| 08/01/2018 | 41.24% | Roth Capital | → $12.5 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 02/10/2023 | 63.84% | 聯盟全球合作夥伴 | $16.5→$14.5 | 維護 | 買 |
| 11/04/2022 | 86.44% | 聯盟全球合作夥伴 | $17.5→$16.5 | 維護 | 買 |
| 05/06/2022 | 80.79% | HC Wainwright公司 | $13→$16 | 維護 | 買 |
| 03/03/2022 | 46.89% | HC Wainwright公司 | $12→$13 | 維護 | 買 |
| 02/14/2022 | 35.59% | HC Wainwright公司 | $10→$12 | 維護 | 買 |
| 12/02/2021 | 12.99% | HC Wainwright公司 | $9→$10 | 維護 | 買 |
| 2021年11月05日 | 1.69% | HC Wainwright公司 | $7→$9 | 維護 | 買 |
| 08/06/2021 | -20.9% | HC Wainwright公司 | $6→$7 | 維護 | 買 |
| 03/01/2021 | -32.2% | HC Wainwright公司 | $4→$6 | 維護 | 買 |
| 02/26/2021 | -32.2% | 羅斯資本 | $4→$6 | 維護 | 買 |
| 11/09/2020 | -54.8% | HC Wainwright公司 | $5→$4 | 維護 | 買 |
| 05/11/2020 | -66.1% | B.萊利證券 | $5.5→$3 | 維護 | 中性 |
| 05/08/2020 | -43.5% | HC Wainwright公司 | $8→$5 | 重申 | →購買 |
| 2019/07/11 | -37.85% | B.萊利證券 | $14→$5.5 | 評級下調 | 購買→中性 |
| 2018年09月19日 | 12.99% | Maxim集團 | $9→$10 | 維護 | 買 |
| 2018年08月27日 | 58.19% | HC Wainwright公司 | →$14 | 開始承保 | →購買 |
| 2018年08月01日 | 41.24% | 羅斯資本 | →$12.5 | 開始承保 | →購買 |
What is the target price for Sensus Healthcare (SRTS)?
人口普查醫療(SRTS)的目標價格是多少？
The latest price target for Sensus Healthcare (NASDAQ: SRTS) was reported by Alliance Global Partners on February 10, 2023. The analyst firm set a price target for $14.50 expecting SRTS to rise to within 12 months (a possible 63.84% upside). 5 analyst firms have reported ratings in the last year.
聯盟全球合作夥伴於2023年2月10日報告了人口普查醫療(納斯達克：SRTS)的最新目標價。這家分析公司將目標價定為14.50美元，預計SRT將在12個月內升至(可能上漲63.84%)。去年有5家分析公司公佈了評級。
What is the most recent analyst rating for Sensus Healthcare (SRTS)?
人口普查醫療(SRTS)的最新分析師評級是多少？
The latest analyst rating for Sensus Healthcare (NASDAQ: SRTS) was provided by Alliance Global Partners, and Sensus Healthcare maintained their buy rating.
納斯達克：SRTS)的最新分析師評級由聯盟全球合作夥伴提供，人口普查醫療維持買入評級。
When is the next analyst rating going to be posted or updated for Sensus Healthcare (SRTS)?
人口普查醫療(SRTS)的下一次分析師評級將於何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sensus Healthcare, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sensus Healthcare was filed on February 10, 2023 so you should expect the next rating to be made available sometime around February 10, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括查閱公共財務報表，與Scount Healthcare的高管和客戶交談，以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次，所以你每年應該會得到每家公司每家公司的4個評級。人口普查醫療保健的上一次評級是在2023年2月10日提交的，所以你應該預計下一次評級將在2024年2月10日左右的某個時候提供。
Is the Analyst Rating Sensus Healthcare (SRTS) correct?
分析師對人口普查醫療保健(SRTS)的評級正確嗎？
While ratings are subjective and will change, the latest Sensus Healthcare (SRTS) rating was a maintained with a price target of $16.50 to $14.50. The current price Sensus Healthcare (SRTS) is trading at is $8.85, which is out of the analyst's predicted range.
雖然評級是主觀的，並將發生變化，但最新的人口普查醫療(SRTS)評級保持不變，目標價在16.50美元至14.50美元之間。目前Scount Healthcare(SRTS)的交易價格為8.85美元，超出了分析師的預測範圍。